Consolidated Statements of Assets and Liabilities (Parenthetical) - USD ($) $ in Thousands |
Jun. 30, 2025 |
Dec. 31, 2024 |
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Consolidated Statements of Assets and Liabilities | ||||||||||||||||||||||||
Cost | $ 2,649,172 | [1],[2],[3],[4],[5] | $ 2,502,807 | [6],[7],[8],[9],[10] | ||||||||||||||||||||
Net of deferred financing costs | 9,921 | 11,346 | ||||||||||||||||||||||
Net of debt issuance costs | $ 5,650 | $ 2,728 | ||||||||||||||||||||||
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 | ||||||||||||||||||||||
Preferred stock, shares authorized (in shares) | 1,000,000 | 1,000,000 | ||||||||||||||||||||||
Preferred stock, shares issued (in shares) | 0 | 0 | ||||||||||||||||||||||
Preferred stock, shares outstanding (in shares) | 0 | 0 | ||||||||||||||||||||||
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 | ||||||||||||||||||||||
Common stock, shares authorized (in shares) | 250,000,000 | 250,000,000 | ||||||||||||||||||||||
Common stock, shares issued (in shares) | 63,830,398 | 63,054,004 | ||||||||||||||||||||||
Common stock, shares outstanding (in shares) | 63,830,398 | 63,054,004 | ||||||||||||||||||||||
|